These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 27353537)

  • 1. Biomarker Tests for Molecularly Targeted Therapies--The Key to Unlocking Precision Medicine.
    Lyman GH; Moses HL
    N Engl J Med; 2016 Jul; 375(1):4-6. PubMed ID: 27353537
    [No Abstract]   [Full Text] [Related]  

  • 2. Expansion of protections to all human research participants.
    Maloney DM
    Hum Res Rep; 2002 Dec; 17(12):1-2. PubMed ID: 12731499
    [No Abstract]   [Full Text] [Related]  

  • 3. Wiser investment for a healthier future.
    Teutsch SM; Baciu AB; Mays GP; Getzen TE; Hansen MM; Geller AB
    J Public Health Manag Pract; 2012; 18(4):295-8. PubMed ID: 22635180
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter from North America: The United States government's comparative effectiveness research program.
    Sakala C
    Birth; 2009 Dec; 36(4):342-4. PubMed ID: 20002428
    [No Abstract]   [Full Text] [Related]  

  • 5. Institute of Medicine outlines priorities for comparative effectiveness research.
    Kuehn BM
    JAMA; 2009 Sep; 302(9):936-7. PubMed ID: 19724034
    [No Abstract]   [Full Text] [Related]  

  • 6. Organ transplant panel urges a broad sharing of livers.
    Stolberg SG
    N Y Times Web; 1999 Jul; ():A14. PubMed ID: 11648120
    [No Abstract]   [Full Text] [Related]  

  • 7. Science and government. Review for NCCAM is overdue.
    Marcus DM; Grollman AP
    Science; 2006 Jul; 313(5785):301-2. PubMed ID: 16857923
    [No Abstract]   [Full Text] [Related]  

  • 8. Implications of the Institute of Medicine Report: Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease.
    Wagner JA; Ball JR
    Clin Pharmacol Ther; 2015 Jul; 98(1):12-5. PubMed ID: 25833004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influencing cancer policy.
    Herdman R; McGuire W; Simone J
    Health Aff (Millwood); 2006; 25(3):800-7. PubMed ID: 16684746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expert panel sees poor leadership in U.S. AIDS battle.
    Boffey PM
    N Y Times Web; 1988 Jun; ():A1, B13. PubMed ID: 11646682
    [No Abstract]   [Full Text] [Related]  

  • 11. Healthcare on report. IOM president, just one year into his term, vows to build on organization's groundbreaking studies.
    Morrissey J
    Mod Healthc; 2003 Aug; 33(31):30-1. PubMed ID: 12931479
    [No Abstract]   [Full Text] [Related]  

  • 12. Research integrity. U.S. universities urged to do a better job.
    Kaiser J
    Science; 2002 Jul; 297(5580):321. PubMed ID: 12130761
    [No Abstract]   [Full Text] [Related]  

  • 13. Funding health sciences research: a strategy to restore balance.
    Bloom FE; Bulger RE; Randolph MA
    Clin Res; 1990 Dec; 38(4):671-85. PubMed ID: 2177388
    [No Abstract]   [Full Text] [Related]  

  • 14. Blueprint for a stronger Food and Drug Administration.
    Curfman GD; Morrissey S; Drazen JM
    N Engl J Med; 2006 Oct; 355(17):1821. PubMed ID: 17030844
    [No Abstract]   [Full Text] [Related]  

  • 15. New rules for research with human participants?
    Berg J; Deming N
    Hastings Cent Rep; 2011; 41(6):10-1. PubMed ID: 22238896
    [No Abstract]   [Full Text] [Related]  

  • 16. Medical devices and health--creating a new regulatory framework for moderate-risk devices.
    Challoner DR; Vodra WW
    N Engl J Med; 2011 Sep; 365(11):977-9. PubMed ID: 21830961
    [No Abstract]   [Full Text] [Related]  

  • 17. Federally funding human embryonic stem cell research: an administrative analysis.
    Gross GS
    Wis L Rev; 2000; 4():855-84. PubMed ID: 12664903
    [No Abstract]   [Full Text] [Related]  

  • 18. Codevelopment of genome-based therapeutics and companion diagnostics: insights from an Institute of Medicine roundtable.
    McCormack RT; Armstrong J; Leonard D
    JAMA; 2014 Apr; 311(14):1395-6. PubMed ID: 24522512
    [No Abstract]   [Full Text] [Related]  

  • 19. Stimulus funds force hard look at comparative effectiveness research.
    Tuma RS
    J Natl Cancer Inst; 2009 Aug; 101(15):1036-9. PubMed ID: 19638502
    [No Abstract]   [Full Text] [Related]  

  • 20. IOM: overhaul drug safety monitoring.
    Kuehn BM
    JAMA; 2006 Nov; 296(17):2075-6. PubMed ID: 17077364
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.